INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
A CLINICAL STUDY ON WAJA-UL-MUFASIL(RHEUMATOID
ARTHRITIS) AND ITS MANAGEMENT IN UNANI MEDICINE
*Dr..Sheema Mariyam **Dr..N.Narasimha MD (Professor)
***Dr.. Mohammed Ahsan Faroqui, HOD PG.dept. of Moalejat.
Govt. Niazmia Tibbi College Charminar, Hyd.
ABSTRACT:
Introduction: Rheumatoid arthritis (RA) is a long-standing inflammatory condition of
undetermined causative factors with the hallmark of symmetric joint involvement. It is
an autoimmune disease in which the body's immune system of the patient innocently
targets its own body tissues. It principally attacks the synovial membrane. The most
prevalent inflammatory arthritic condition, Rheumatoid arthritis (RA) affects 0.5% to
1% of the global population. It affects 15% (180 million) of the population of India. In
the classical Unani literature, waja-ul-mufasil (RA) occurs in various joints caused by
derangement of the body’s natural humours i.e., dam (blood), balgham (phlegm),
safra (bile), and sauda (black bile) with various explanations mentioned by great
scholars in Unani literature.The onset of the disease is insidious, beginning with
prodrome of fatigue, weakness, joint stiffness, vague arthralgias and myalgias
followed by pain and swelling. The most common age of onset is between 30 and 50
years.The cause is multifactorial and genetic and environmental factors play a part.
Female gender is more susceptible.
AIMS & OBJECTIVES: To evaluate the safety and efficacy of unani drugs in cases
of Waja-ul-Mufasil (Rheumatoid Arthritis) and to prevent the long term side effects of
DMARD’S, NSAID’S and CORTICOSTEROIDS.
Methodology: The study of Waja-ul-Mufasil (Rheumatoid Arthritis) and its
management with unani medicine was carried out in OPD of Govt. Nizamia General
Hospital, Charminar, Hyderabad. It is A Single blind clinical trial to evaluate the safety
and efficacy of Waja-ul -Mufasil (Rheumatoid Arthritis) with polyherbal unani
formulation. Sample size of RA is 40 patients of either sex 18-50 years were taken. In
this study patients were given polyherbal unani formulation for the total duration of
treatment of 51 days i.e., orally in the form of decoction for 21 days based on
formulations of unani Drugs having properties like Mushil balgham o sauda
(Purgative), Mohalil e auram (Resolvent). After the period of 21 days of decoction,
patients were given unani medicine possessing the properties of Musaffi khoon (Blood
purifier), Musakkin Alam (Analgesic), Muqavvi Aasab (Nervine tonic) for next 30 days.
Results and Conclusion: The study revealed that the drug showed extreme
statistical significance P value <0.0001 in subjective parameters like Pain,
Tenderness, Swelling, Morning stiffness, and Any deformity. The objective parameters
like RA factor, ESR also showed the significant difference P value <0.0001. No
adverse effect or toxicity was observed during clinical trial.
Keywords:
Key word: Waja-ul-Mufasil (Rheumatoid Arthritis), Autoimmune disease, Unani medicines, Humours, Mushil balgham o sauda (Purgative), Mohalil e auram (Resolvent), Musaffi khoon (Blood purifier), Musakkin Alam (Analgesic), Muqavvi Aasab (Nervine tonic).
Cite Article:
"A CLINICAL STUDY ON WAJA-UL-MUFASIL (RHEUMATOID ARTHRITIS) AND ITS MANAGEMENT IN UNANI MEDICINE", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.9, Issue 3, page no.c504-c529, March-2024, Available :http://www.ijnrd.org/papers/IJNRD2403267.pdf
Downloads:
00037
ISSN:
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Facebook Twitter Instagram LinkedIn